World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   9863 records for 1817 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
RecruitingNoISRCTN51761666
Effect of the probiotic strain TENSIA® DSM21380 on high-normal blood pressure and up to grade-1 hypertension
11/06/2018Yes
Not RecruitingYesCTRI/2018/06/014445
International study of Rigosertib versus doctorâ??s choice of treatment in patients suffering from Myelodysplastic Syndrome after Failure of a Hypomethylating Agent
07-06-2018 
Not RecruitingYesCTRI/2018/05/014044
To Study of CLS-Triamnicolone Acetonide in combination with an anti-VEGF agent in Subjects with Retinal Vein Occlusion
22-05-2018 
Not RecruitingYesCTRI/2018/05/014027
A study to find out if study molecule SHP640(PVP-Iodine 0.6% and Dexamethasone 0.1%) is effective in comparison to PVP-Iodine and Placebo for treating conjunctivitis which is an eye disease.
21-05-2018 
AuthorisedYesEUCTR2017-003692-61-EE
A study to investigate the safety and immunogenicity of different formulations of GSK Biologicals’ Meningococcal ACWY conjugate vaccine (GSK3536820A and Menveo) administered to healthy adults 18 to 40 years of age
14/05/2018 
Not AvailableYesEUCTR2017-000617-23-BE
Research study to determine whether an investigational drug, SHP647, is safe and effective in the treatment of moderate to severe Crohn’s Disease, compared with placebo (dummy treatment) – using a randomised and blinded study design (investigator and patients are not aware whether they receive study drug or placebo. 02/05/2018 
Not AvailableYesEUCTR2017-000576-29-BE
Research study to determine whether an investigational drug, SHP647, is safe and effective in the treatment of moderate to severe Crohn’s Disease, compared with placebo (dummy treatment) – using a randomised and blinded study design (investigator and patients are not aware whether they receive study drug or placebo)(CARMEN CD 306).
02/05/2018 
Not AvailableYesEUCTR2017-000617-23-AT
Research study to determine whether an investigational drug, SHP647, is safe and effective in the treatment of moderate to severe Crohn’s Disease, compared with placebo (dummy treatment) – using a randomised and blinded study design (investigator and patients are not aware whether they receive study drug or placebo.
19/04/2018 
AuthorisedYesEUCTR2017-004886-29-EE
A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients with Multiple Sclerosis Previously Enrolled in A F. Hoffmann-la Roche Sponsored Ocrelizumab Clinical Trial
18/04/2018 
Not AvailableYesEUCTR2017-005153-37-EE
A controlled multicenter study to assess efficacy and safety of LJPC-501 in children > 2 to 17 years of age with severely low blood pressure associated with shock
18/04/2018 
      
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history